(DMEC) Desjardins Canadian Equity - Ratings and Ratios
Canadian, Equity, Shares, Units, ETF
Description: DMEC Desjardins Canadian Equity
The Desjardins Canadian Equity Index ETF (TO:DMEC) is a Canadian equity exchange-traded fund (ETF) that tracks the Morningstar Canada Gross Return (GR) CAD Index, providing broad exposure to the Canadian equity market. With a focus on replicating the performance of the underlying index, this ETF offers investors a diversified portfolio of Canadian equities.
Analyzing the ETFs technical data, we observe a current price of $24.81, indicating a strong upward trend as it is above its 20-day Simple Moving Average (SMA) of $24.57 and 50-day SMA of $23.85. The 200-day SMA at $22.91 further supports the bullish sentiment, as the price is significantly above this long-term average. The Average True Range (ATR) of 0.13, or 0.51%, suggests relatively low volatility. Given these technical indicators, we can anticipate a potential continuation of the upward trend, with a possible target near the 52-week high of $24.81 or slightly higher, assuming the current momentum is sustained.
From a fundamental perspective, the Desjardins Canadian Equity Index ETF boasts Assets Under Management (AUM) of $586.06 million CAD, indicating a moderate size that can provide liquidity without being too capital-intensive. This size, combined with its tracking of a broad Canadian equity index, positions the ETF as a potentially stable investment for those seeking exposure to the Canadian market.
Forecasting the future performance of DMEC involves integrating both technical and fundamental data. Given the ETFs current technical trends and its fundamental characteristics, a potential short-term target could be a price slightly above $25.00, assuming the continuation of the current trend and low volatility. However, its crucial to monitor changes in the underlying index, overall market conditions, and any shifts in investor sentiment towards Canadian equities. A sustained break below the 50-day SMA could indicate a reversal in trend, warranting a reassessment of the investment thesis.
Investors considering DMEC should be aware of the broader market context and the specific composition of the Morningstar Canada GR CAD Index. The ETFs performance is closely tied to the Canadian equity markets overall direction, making it essential to monitor economic indicators, sector rotations, and any significant changes in the Canadian market landscape.
DMEC ETF Overview
| Market Cap in USD | 628m |
| Category | Canadian Equity |
| IPO / Inception | 2024-04-15 |
DMEC ETF Ratings
| Growth Rating | 51.2 |
| Fundamental | - |
| Dividend Rating | 22.5 |
| Rel. Strength | 5.13 |
| Analysts | - |
| Fair Price Momentum | 25.99 CAD |
| Fair Price DCF | - |
DMEC Dividends
| Dividend Yield 12m | 1.98% |
| Yield on Cost 5y | 2.50% |
| Annual Growth 5y | -12.94% |
| Payout Consistency | 100.0% |
| Payout Ratio | % |
DMEC Growth Ratios
| Growth Correlation 3m | 98.2% |
| Growth Correlation 12m | 82.5% |
| Growth Correlation 5y | 91.7% |
| CAGR 5y | 24.78% |
| CAGR/Max DD 5y | 2.04 |
| Sharpe Ratio 12m | 2.30 |
| Alpha | 13.40 |
| Beta | 0.570 |
| Volatility | 10.94% |
| Current Volume | 49k |
| Average Volume 20d | 6.5k |
| Stop Loss | 25.2 (-3.1%) |
What is the price of DMEC shares?
As of August 13, 2025, the stock is trading at CAD 26.00 with a total of 49,045 shares traded.Over the past week, the price has changed by +1.44%, over one month by +2.81%, over three months by +10.17% and over the past year by +28.37%.
Is Desjardins Canadian Equity a good stock to buy?
Partly, yes. Based on ValueRay´s Analyses, Desjardins Canadian Equity (TO:DMEC) is currently (August 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 51.23 and therefor an somewhat technical positive rating according to historical growth.Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of DMEC is around 25.99 CAD . This means that DMEC is currently overvalued and has a potential downside of -0.04%.
Is DMEC a buy, sell or hold?
Desjardins Canadian Equity has no consensus analysts rating.What are the forecasts/targets for the DMEC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 28.9 | 11.1% |
DMEC Fundamental Data Overview
Market Cap CAD = 864.5m (864.5m CAD * 1.0 CAD.CAD)
CCE Cash And Equivalents = unknown
Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 CAD
Beta = 0.0
Revenue TTM = 0.0 CAD
EBIT TTM = 0.0 CAD
EBITDA TTM = 0.0 CAD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 864.5m CAD (864.5m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 864.5m)
FCF Margin = unknown (Revenue TTM is 0)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 864.5m / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = unknown
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = none (Debt none / FCF TTM 0.0)
Total Stockholder Equity = unknown
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
RoIC = unknown (NOPAT none, Invested Capital 0.0, Ebit 0.0)
WACC = unknown (E(864.5m)/V(0.0) * Re(8.12%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(none)))
Discount Rate = 8.12% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)